Fed. Circ.'s UT Immunity Ruling Places Licensing In Spotlight
By Dani Kass (July 31, 2020, 5:02 PM EDT) -- The Federal Circuit's recent decision expanding the University of Texas' sovereign immunity while letting a licensee pursue infringement litigation alone is raising a host of questions about how private companies and public universities should approach patent licensing agreements.
It's been well established that the 11th Amendment protects state entities like universities from being sued for patent infringement. But in a July 24 precedential opinion, a deeply fractured Federal Circuit panel said that same immunity bars universities from being added as co-plaintiffs without their consent.
More specifically, the panel concluded that UT didn't waive its sovereign immunity when it licensed cancer therapy patents to Gensetix...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!